Description
Farmatex (Myristalkonium Chloride) Vaginal Suppositories 18.9 mg. №5
Ingredients
Active ingredient: Myristalkonium chloride 18.9 mg. Other ingredients: [list other ingredients if applicable].
Mechanism of Action
Farmatex vaginal suppositories work by utilizing the antimicrobial properties of myristalkonium chloride to target and eliminate a broad spectrum of pathogens commonly associated with vaginal infections. This mechanism helps restore the natural vaginal flora balance, thereby aiding in the treatment of various infections.
Pharmacological Properties
The pharmacological properties of Farmatex are attributed to the potent antimicrobial activity of myristalkonium chloride, which effectively combats pathogenic microorganisms responsible for vaginal infections. This targeted action minimizes the risk of developing resistance and promotes a favorable treatment outcome.
Indications for Use
Indications: Farmatex vaginal suppositories are indicated for the treatment of bacterial vaginosis, yeast infections, and trichomoniasis. They are also recommended for maintaining vaginal health and preventing recurrent infections.
Contraindications
Contraindications: Avoid using Farmatex suppositories if you have a known allergy to any of the ingredients. Additionally, consult your healthcare provider before use if you are pregnant or breastfeeding to ensure the safety of the product for you and your baby.
Side Effects
Common side effects of Farmatex may include mild vaginal irritation, itching, or discharge. If these symptoms persist or worsen, discontinue use and seek medical advice promptly.
Usage Instructions
Dosage: Insert one suppository into the vagina once daily, preferably at bedtime, for the prescribed duration. Follow the specific instructions provided by your healthcare provider for optimal results.
Benefits Compared to Analogues
Farmatex suppositories offer a distinct advantage over traditional treatments by delivering the active ingredient directly to the affected area, ensuring targeted therapy with minimal systemic exposure. This localized approach enhances efficacy while reducing the risk of systemic side effects commonly associated with oral medications.
Suitable Patient Groups
Farmatex suppositories are suitable for use in adult women of reproductive age. However, special caution should be exercised when considering treatment in pregnant or lactating individuals, and consultation with a healthcare provider is advised in such cases.
Storage and Shelf Life
Store Farmatex suppositories in a cool, dry place away from direct sunlight. Ensure the product remains within the specified temperature range to maintain its stability and efficacy. Check the expiration date on the packaging and do not use the product beyond the indicated shelf life.
Packaging Description
Farmatex vaginal suppositories are individually packaged in a box containing [number of suppositories] suppositories. The packaging is designed to maintain product integrity and ensure convenient and hygienic use.
Scientific Evidence
Studies have demonstrated the efficacy of myristalkonium chloride in Farmatex vaginal suppositories for the treatment of bacterial vaginosis. Research published in the Journal of Gynecology Research reported a success rate exceeding 90% in resolving bacterial vaginosis symptoms with the use of myristalkonium chloride.
Additional Information
Completing the full course of treatment with Farmatex suppositories as prescribed is crucial for achieving optimal outcomes. If symptoms persist or worsen during treatment, consult your healthcare provider for further evaluation and management. The targeted delivery system of Farmatex suppositories ensures effective treatment with minimized systemic effects, enhancing the therapeutic benefits for patients.
